Skip to main content
. 2019 Apr 18;11:3371–3379. doi: 10.2147/CMAR.S187233

Table 2.

Treatment for patients in the two ALC cohorts

Characteristics Overall, n(%) ALC p-value
<1.8 ≥1.8
Chemotherapy EC-T 300(81.7) 144 156 0.581
TCb 41(11.2) 18 23
P 21(5.7) 11 10
Others 5(1.4) 1 4
Radiation Yes 207(56.4) 100 107 0.695
No 160(43.6) 74 86
Endocrine therapy Yes 160(43.6) 77 83 0.810
No 207(56.4) 97 110

Abbreviations: EC-T, epirubicin and cyclophosphamide followed by docetaxel; TCb, docetaxel and carboplatin; P, paclitaxel; ALC, absolute lymphocyte count.